7 news items
Nevro to Present at BofA Securities 2024 Healthcare Conference
NVRO
9 May 24
. (NYSE:NVRO), a global medical device company that is delivering comprehensive, life-changing solutions for the treatment of chronic pain
Assessing Nevro: Insights From 9 Financial Analysts
NVRO
8 May 24
, an evidence-based neuromodulation system for the treatment of chronic pain. Senza generates electrical impulses to relieve pain. The system is implanted
Nevro to Report First-Quarter 2024 Financial Results and Host Earnings Conference Call on May 7, 2024
NVRO
17 Apr 24
. (NYSE:NVRO), a global medical device company delivering comprehensive, life-changing solutions for the treatment of chronic pain, today
Non-Opioid Revolution: Beacons of Hope in Opioid Crisis and a $50 Million Spin-Off
MDT
NVRO
9 Apr 24
be effective in reducing and managing pain from various conditions, including surgical procedures, chronic back pain, arthritis, neuropathy
Where Nevro Stands With Analysts
NVRO
3 Apr 24
for the treatment of chronic pain. Senza generates electrical impulses to relieve pain. The system is implanted by physicians and controlled by patients
37a9dt
NVRO
28 Feb 24
medical device company delivering comprehensive, life-changing solutions for the treatment of chronic pain, today announced that the U.S. Food and Drug
xppdka3dwb7ad971rjmtq63ojna1kbb
NVRO
22 Feb 24
for the treatment of chronic pain. Senza generates electrical impulses to relieve pain. The system is implanted by physicians and controlled by patients
- Prev
- 1
- Next